Search results
Respiratory Syncytial Virus
American Academy of Pediatrics· 3 days agoRespiratory syncytial virus (RSV) causes acute respiratory tract infections in people of all ages and is one of the most common diseases of early childhood
Glenn Close ‘hit hard’ with Covid and RSV at same time, forced to delay filming ‘Knives Out 3’ | CNN
CNN.com· 3 days agoRespiratory syncytial virus, known as RSV, is a common respiratory virus that typically causes...
Study marks increase in pediatric RSV hospitalizations seen postpandemic
Medical Xpress· 4 days agoHospital volumes for pediatric respiratory syncytial virus (RSV) rose significantly following the...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 6 hours agoBut is Pfizer a value trap? I don't think so. The biopharma giant thinks new products and indications will add around $20 billion to its annual sales by...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 2 days agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Having symptoms after getting a COVID vaccine may indicate robust immune response
Center for Infectious Disease Research and Policy· 5 days agoOne and 6 months after the second vaccine dose, fatigue, malaise, chills, and headache were each...
Boost your immune system with this centuries-old health hack: Vaccines
The Raw Story· 5 hours agoThere are a dizzying number of tips, hacks and recommendations on how to stay healthy, from dietary...
Ottawa Public Health seeking ways to continue wastewater testing
CBC via Yahoo News· 1 day agoOttawa Public Health wants to collaborate with local partners to look for ways to continue...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 6 days agoHowever, the biotech has been looking to move beyond this therapeutic area. It recently earned...